ISG20 levels were increased according to the stage of LC in patients with LC plus HCC (P=0.005) (Figure 2B), but not in LC-only patients as well as in patients with LC (LC only patients and those with LC plus HCC) (Figure 2C and 2D). This evidence concerns the gene ISG20 and hepatocellular carcinoma.